Allurion Technologies Inc. (ALUR)
NYSE · Healthcare · Medical Devices
$0.0210.00%as of Nov 5, 2026, 7:50 AM ET
- Market cap
- $13K
- 52-week range
- $0.01 – $8.52
- 52-week change
- −98.73%
- EPS (trailing)
- −$54.75
Fiscal year to Dec 2025
- Revenue
- $15.2M (−52.57%)
- Net income
- −$28.8M
- Operating margin
- −198.0%
- Diluted EPS
- −$3.81
From the company’s annual report on SEC EDGAR.
About Allurion Technologies Inc.
Allurion Technologies Inc. focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally. Its Allurion Program platform offers the Allurion Smart Capsule, a swallowable and procedure-less intragastric balloon for weight loss, and access to the Allurion Virtual Care Suite, a digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program. The company is headquartered in Natick, Massachusetts.
Headquarters: Natick, United States · 38 employees · allurion.com